Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparisonMark Ainsworth, Christopher J. Groves, Amy Beveridge et al.|The Lancet Infectious Diseases|2020Cited by 405
A blood atlas of COVID-19 defines hallmarks of disease severity and specificityDavid Ahern, Hal Drakesmith, Zhichao Ai et al.|Cell|2022Cited by 327
A blood atlas of COVID-19 defines hallmarks of disease severity and specificityDavid Ahern, Susanna Dunachie, Zhichao Ai et al.|medRxiv|2021Cited by 35